2,500 Shares in Teleflex Incorporated (NYSE:TFX) Bought by Praxis Investment Management Inc.

Praxis Investment Management Inc. purchased a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,500 shares of the medical technology company's stock, valued at approximately $345,000.

Other large investors have also made changes to their positions in the company. CANADA LIFE ASSURANCE Co increased its holdings in Teleflex by 0.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock valued at $3,614,000 after purchasing an additional 74 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its holdings in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares during the last quarter. True Wealth Design LLC increased its holdings in Teleflex by 62.3% in the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock valued at $48,000 after purchasing an additional 104 shares during the last quarter. Isthmus Partners LLC increased its holdings in Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after purchasing an additional 105 shares during the last quarter. Finally, QRG Capital Management Inc. increased its holdings in shares of Teleflex by 5.8% in the fourth quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company's stock worth $388,000 after acquiring an additional 119 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Down 0.2%

Shares of NYSE:TFX traded down $0.19 during mid-day trading on Monday, reaching $118.12. 447,478 shares of the stock were exchanged, compared to its average volume of 629,175. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. The company has a market cap of $5.22 billion, a P/E ratio of 37.26, a P/E/G ratio of 1.85 and a beta of 1.10. Teleflex Incorporated has a one year low of $115.99 and a one year high of $249.91. The stock's 50 day simple moving average is $125.44 and its 200-day simple moving average is $149.63.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.88 by $0.03. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. During the same period in the prior year, the firm posted $3.21 earnings per share. The business's quarterly revenue was down 5.0% compared to the same quarter last year. As a group, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were given a dividend of $0.34 per share. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 annualized dividend and a yield of 1.15%. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Analyst Ratings Changes

Several brokerages have issued reports on TFX. Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Piper Sandler restated a "neutral" rating and issued a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Mizuho set a $155.00 price target on Teleflex in a report on Wednesday, April 16th. Finally, Royal Bank Of Canada lowered their price target on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday, May 2nd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $164.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.